Sharps Technology, Inc. (NASDAQ:STSS) Short Interest Up 236.3% in December

Sharps Technology, Inc. (NASDAQ:STSS) was the target of a large growth in short interest in December. As of December 15th, there was short interest totalling 137,200 shares, a growth of 236.3% from the November 30th total of 40,800 shares. Currently, 7.9% of the shares of the stock are short sold. Based on an average trading volume of 190,600 shares, the days-to-cover ratio is currently 0.7 days.

Sharps Technology Price Performance

Shares of STSS traded down $0.04 on Thursday, reaching $1.97. The stock had a trading volume of 15,595 shares, compared to its average volume of 204,034. The stock has a market cap of $3.54 million, a price-to-earnings ratio of -0.24 and a beta of 1.37. Sharps Technology has a twelve month low of $1.70 and a twelve month high of $18.15. The company’s 50-day moving average is $2.71.

Institutional Investors Weigh In On Sharps Technology

An institutional investor recently bought a new position in Sharps Technology stock. Garden State Investment Advisory Services LLC purchased a new stake in shares of Sharps Technology, Inc. (NASDAQ:STSS) in the third quarter, according to its most recent disclosure with the SEC. The firm purchased 172,909 shares of the company’s stock, valued at approximately $26,000. Garden State Investment Advisory Services LLC owned approximately 9.61% of Sharps Technology at the end of the most recent quarter. Institutional investors own 17.17% of the company’s stock.

About Sharps Technology

Sharps Technology, Inc, a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc was incorporated in 2017 and is based in Melville, New York.